KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Clorox (CLX) over the last 17 years, with Q4 2025 value amounting to $227.0 million.

  • Clorox's Cash & Equivalents fell 2172.41% to $227.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $227.0 million, marking a year-over-year decrease of 2172.41%. This contributed to the annual value of $167.0 million for FY2025, which is 1732.67% down from last year.
  • Latest data reveals that Clorox reported Cash & Equivalents of $227.0 million as of Q4 2025, which was down 2172.41% from $166.0 million recorded in Q3 2025.
  • Over the past 5 years, Clorox's Cash & Equivalents peaked at $518.0 million during Q3 2023, and registered a low of $166.0 million during Q3 2025.
  • Its 5-year average for Cash & Equivalents is $267.0 million, with a median of $234.0 million in 2022.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 7558.14% in 2021, then soared by 11130.95% in 2023.
  • Quarter analysis of 5 years shows Clorox's Cash & Equivalents stood at $192.0 million in 2021, then dropped by 12.5% to $168.0 million in 2022, then skyrocketed by 111.31% to $355.0 million in 2023, then fell by 18.31% to $290.0 million in 2024, then decreased by 21.72% to $227.0 million in 2025.
  • Its last three reported values are $227.0 million in Q4 2025, $166.0 million for Q3 2025, and $167.0 million during Q2 2025.